CVS Health (CVS) Projected to Post Earnings on Tuesday

CVS Health (NYSE:CVS) will likely be releasing its Q4 2025 results before the market opens on Tuesday, February 10th. Analysts expect the company to announce earnings of $0.99 per share and revenue of $103.6718 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, February 10, 2026 at 8:00 AM ET.

CVS Health Stock Up 1.2%

CVS stock opened at $75.43 on Tuesday. The firm has a 50-day moving average price of $78.85 and a 200-day moving average price of $75.33. CVS Health has a 12 month low of $53.36 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $95.76 billion, a P/E ratio of 198.51, a price-to-earnings-growth ratio of 0.69 and a beta of 0.50.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s dividend payout ratio is presently 700.00%.

Institutional Trading of CVS Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CVS. Legacy Advisors LLC acquired a new stake in CVS Health during the third quarter worth approximately $249,000. Resurgent Financial Advisors LLC bought a new position in shares of CVS Health during the 3rd quarter worth approximately $215,000. PFG Advisors acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $205,000. MUFG Securities EMEA plc acquired a new position in shares of CVS Health during the 2nd quarter valued at $258,000. Finally, McIlrath & Eck LLC boosted its stake in CVS Health by 422.9% during the second quarter. McIlrath & Eck LLC now owns 3,383 shares of the pharmacy operator’s stock worth $233,000 after acquiring an additional 2,736 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the topic of a number of research reports. Mizuho boosted their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. JPMorgan Chase & Co. boosted their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Bank of America dropped their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Robert W. Baird boosted their price target on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $94.82.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.